|
Products
Medicure is a leader in the research and commercial development of novel therapeutics targeting unmet needs in the field of cardiovascular medicine, the largest pharmaceutical sector with annual global sales of over US $70 billion/year. It is Medicure's vision to make a worldwide impact on the cardiovascular and stroke markets by reducing related deaths and improving the quality of life for those who suffer from the diseases.
|
|
|
|
.JPG)
|
|
MC-1 has been developed through phase III testing for cardioprotection in coronary artery bypass grafting. While the MC-1 acute cardioprotective program was put on hold, Medicure is continuing to explore new applications for this naturally occurring small molecule that in both preclinical and clinical studies has shown potential for treating various forms of cardiovascular disease and other chronic indications.
|
|
